Susquehanna Portfolio Strategies’s Relay Therapeutics RLAY Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.9M	Sell	101,291 -237,789	-70%	-$3.45M	0.03%	444
2026 Q1	$3.37M	Hold	339,080	–	–	0.05%	379
2025 Q4	$2.87M	Hold	339,080	–	–	0.04%	426
2025 Q3	$1.77M	Buy	339,080 +100,266	+42%	+$382K	0.03%	536
2025 Q2	$826K	Buy	+238,814	New	+$710K	0.02%	549
2024 Q4	–	Sell	-130,000	Closed	-$920K	–	263
2024 Q3	$920K	Sell	130,000 -78,356	-38%	-$585K	0.06%	203
2024 Q2	$1.36M	Hold	208,356	–	–	0.06%	254
2024 Q1	$1.73M	Sell	208,356 -1,647	-0.8%	-$16.1K	0.04%	360
2023 Q4	$2.31M	Buy	+210,003	New	+$1.77M	0.04%	402

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Susquehanna Portfolio Strategies's RLAY Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Relay Therapeutics (RLAY) stake by 70% in Q2 2026, selling an estimated $3.45M and leaving 101,291 shares worth $1.9M. The position accounts for 0.03% of the portfolio, ranked #444.

Susquehanna Portfolio Strategies first reported a position in RLAY in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.37M in Q1 2026. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Susquehanna Portfolio Strategies held 101,291 shares of Relay Therapeutics worth $1.9M as of Q2 2026.
Susquehanna Portfolio Strategies sold 237,789 Relay Therapeutics shares in Q2 2026, an estimated $3.45M.
Relay Therapeutics made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #444 holding.
Susquehanna Portfolio Strategies first reported a position in Relay Therapeutics in Q4 2023 and has held it in 9 quarters since.
Susquehanna Portfolio Strategies's Relay Therapeutics position peaked at $3.37M in Q1 2026.
258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.